Delving into the Latest Updates on Adipose derived MSC cell(Bopin (Shanghai) Biomedical Technology) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism

Stem cell replacements

Therapeutic Areas

Skin and Musculoskeletal Diseases

Active Indication

Osteoarthritis, Knee

Inactive Indication-

Originator Organization

Bopin (Shanghai) Biomedical Technology Co., Ltd.

Active Organization

Bopin (Shanghai) Biomedical Technology Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

Main purpose: Evaluate the clinical safety and tolerability of hADSCs in the treatment of subjects with knee osteoarthritis, and recommend a safe dose range and RP2D for subsequent studies of this product. Secondary purpose: Preliminary evaluation of the effectiveness of hADSCs in the treatment of subjects with knee osteoarthritis, and provide a basis for the design of subsequent clinical trial programs.

Start Date16 Mar 2023

Sponsor / Collaborator

Bopin (Shanghai) Biomedical Technology Co., Ltd.

[+1]

100 Clinical Results associated with Adipose derived MSC cell(Bopin (Shanghai) Biomedical Technology)

Login to view more data

100 Translational Medicine associated with Adipose derived MSC cell(Bopin (Shanghai) Biomedical Technology)

Login to view more data

100 Patents (Medical) associated with Adipose derived MSC cell(Bopin (Shanghai) Biomedical Technology)

Login to view more data

100 Deals associated with Adipose derived MSC cell(Bopin (Shanghai) Biomedical Technology)

Login to view more data